AI assistant
Solana Co — Director's Dealing 2017
Dec 26, 2017
32724_dirs_2017-12-26_f30bffe6-4291-4ec0-9f8b-d60ea942a0ce.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2017-12-22
Reporting Person: Deschamps Philippe (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-22 | Class A Common Stock | P | 127551 | $1.96 | Acquired | 3334556 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-12-22 | Warrant (Right to Buy) | $2.45 | P | 127551 | Acquired | 2020-12-22 | Class A Common Stock (127551) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class A Common Stock | 54886 | Direct |
Footnotes
F1: These securities were purchased by Deschamps Global Healthcare Commercialization LLC (the "LLC"). The Reporting Person is the sole member of the LLC.
F2: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $1.96.
F3: Represents shares directly held by the LLC and includes shares previously held directly by MPJ Healthcare, LLC ("MPJ"). The Reporting Person is a member of MPJ and is the sole member of the LLC.
F4: Immediately exercisable.